{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:18:04Z","timestamp":1788020284141,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trsl.2026.07.016","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T18:47:28Z","timestamp":1785696448000},"page":"173-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PARP7 enhances doxorubicin-induced cardiomyocyte ferroptosis and cardiotoxicity by ADP-ribosylation-dependent suppression of GPX4 activity"],"prefix":"10.1016","volume":"296","author":[{"given":"Yiting","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.07.016_bib0001","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death","volume":"18","author":"Kong","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.trsl.2026.07.016_bib0002","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trsl.2026.07.016_bib0003","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2352-4642(22)00239-5","article-title":"Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International late effects of childhood cancer guideline harmonization group","volume":"6","author":"de Baat","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.trsl.2026.07.016_bib0004","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.cell.2023.08.030","article-title":"ADP-ribosylation from molecular mechanisms to therapeutic implications","volume":"186","author":"Suskiewicz","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.07.016_bib0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/med.22069","article-title":"The recent advance and prospect of poly(ADP-ribose) polymerase inhibitors for the treatment of cancer","volume":"45","author":"Bai","year":"2025","journal-title":"Med Res Rev"},{"key":"10.1016\/j.trsl.2026.07.016_bib0006","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1101\/gad.334425.119","article-title":"The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions","volume":"34","author":"Fehr","year":"2020","journal-title":"Genes Dev"},{"key":"10.1016\/j.trsl.2026.07.016_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104261","article-title":"Poly (ADP-ribose) polymerase pathway inhibitor (Olaparib) upregulates SERCA2a expression and attenuates doxorubicin-induced cardiomyopathy in mice","volume":"103","author":"Elkatary","year":"2023","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.trsl.2026.07.016_bib0008","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jacbts.2023.10.009","article-title":"Molecular mechanisms and therapeutic targeting of ferroptosis in doxorubicin-induced cardiotoxicity","volume":"9","author":"Wu","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.trsl.2026.07.016_bib0009","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241184","article-title":"PARP7 inhibits type I interferon signaling to prevent autoimmunity and lung disease","volume":"222","author":"Jeltema","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.07.016_bib0010","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/acs.jmedchem.3c01764","article-title":"Discovery of highly selective PARP7 inhibitors with a novel scaffold for cancer immunotherapy","volume":"67","author":"Gu","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.trsl.2026.07.016_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70013","article-title":"PARP7i Clinical candidate RBN-2397 exerts antiviral activity by modulating interferon-\u03b2 associated innate immune response in macrophages","volume":"85","author":"Du","year":"2024","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.trsl.2026.07.016_bib0012","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Sci (N Y NY)"},{"key":"10.1016\/j.trsl.2026.07.016_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.05.039","article-title":"Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity","volume":"186","author":"Lei","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.07.016_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.122.321587","article-title":"Critical role of the cGAS-STING pathway in doxorubicin-induced cardiotoxicity","volume":"132","author":"Luo","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2026.07.016_bib0015","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1038\/s41467-025-61028-1","article-title":"Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male mice","volume":"16","author":"Han","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.07.016_bib0016","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s44161-023-00313-y","article-title":"Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes","volume":"2","author":"Han","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.trsl.2026.07.016_bib0017","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.apsb.2025.03.051","article-title":"Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STING","volume":"15","author":"Lin","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.trsl.2026.07.016_bib0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trsl.2022.05.001","article-title":"Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage","volume":"248","author":"Ye","year":"2022","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2026.07.016_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103024","article-title":"Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy","volume":"70","author":"Huang","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.trsl.2026.07.016_bib0020","doi-asserted-by":"crossref","first-page":"19846","DOI":"10.1021\/acs.jmedchem.5c01335","article-title":"PARP7: an emerging therapeutic target-insights into biological functions and advances in small-molecule inhibitor development","volume":"68","author":"Qiu","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.trsl.2026.07.016_bib0021","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","article-title":"Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.trsl.2026.07.016_bib0022","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/HYPERTENSIONAHA.124.23823","article-title":"MYSM1 Mediates cardiac parthanatos and hypertrophy by deubiquitinating PARP1","volume":"82","author":"Zhong","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2026.07.016_bib0023","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s10495-023-01929-y","article-title":"PARP-2 mediates cardiomyocyte aging and damage induced by doxorubicin through SIRT1 inhibition","volume":"29","author":"Huang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.trsl.2026.07.016_bib0024","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.07.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the crossroads of lipid homeostasis and ferroptosis","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.trsl.2026.07.016_bib0026","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210050","article-title":"SUMOylation modification-mediated cell death","volume":"11","author":"Sheng","year":"2021","journal-title":"Open Biol"},{"key":"10.1016\/j.trsl.2026.07.016_bib0027","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41419-025-07807-6","article-title":"Targeting the TRIM14\/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC","volume":"16","author":"Yue","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2026.07.016_bib0028","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2026.07.016_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2015.08.001","article-title":"Cardiac gene therapy: recent advances and future directions","volume":"215","author":"Mason","year":"2015","journal-title":"J Control Release"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:33:18Z","timestamp":1788017598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"alternative-id":["S1931524426001660"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.07.016","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP7 enhances doxorubicin-induced cardiomyocyte ferroptosis and cardiotoxicity by ADP-ribosylation-dependent suppression of GPX4 activity","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}